AT Bancorp’s Pfizer PFE Stock Holding History

AT Bancorp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$851K	Sell	21,112 -1,375	-6%	-$55.1K	0.1%	111
2018 Q4	$931K	Sell	22,487 -146	-0.6%	-$6.06K	0.12%	97
2018 Q3	$946K	Sell	22,633 -25	-0.1%	-$962	0.1%	108
2018 Q2	$780K	Sell	22,658 -1,061	-4%	-$36.3K	0.09%	112
2018 Q1	$798K	Buy	23,719 +597	+3%	+$20.5K	0.09%	114
2017 Q4	$795K	Buy	23,122 +287	+1%	+$9.79K	0.09%	120
2017 Q3	$773K	Sell	22,835 -14,460	-39%	-$465K	0.09%	114
2017 Q2	$1.19M	Sell	37,295 -19,160	-34%	-$604K	0.14%	83
2017 Q1	$1.83M	Buy	56,455 +8,143	+17%	+$257K	0.23%	76
2016 Q4	$1.49M	Sell	48,312 -25,140	-34%	-$767K	0.2%	92
2016 Q3	$2.36M	Buy	73,452 +49,931	+212%	+$1.67M	0.32%	72
2016 Q2	$786K	Buy	23,521 +8	+0%	+$255	0.12%	151
2016 Q1	$661K	Sell	23,513 -794	-3%	-$22.7K	0.1%	152
2015 Q4	$745K	Sell	24,307 -76	-0.3%	-$2.39K	0.21%	110
2015 Q3	$727K	Buy	24,383 +597	+3%	+$19.1K	0.21%	107
2015 Q2	$757K	Sell	23,786 -184	-0.8%	-$6K	0.19%	116
2015 Q1	$791K	Sell	23,970 -2,823	-11%	-$89.8K	0.22%	114
2014 Q4	$792K	Sell	26,793 -89	-0.3%	-$2.55K	0.24%	106
2014 Q3	$755K	Sell	26,882 -1,691	-6%	-$47.5K	0.22%	111
2014 Q2	$805K	Buy	28,573 +826	+3%	+$23.5K	0.24%	103
2014 Q1	$846K	Sell	27,747 -77,595	-74%	-$2.31M	0.26%	94
2013 Q4	$3.06M	Buy	105,342 +316	+0.3%	+$9.2K	0.94%	42
2013 Q3	$2.86M	Sell	105,026 -3,600	-3%	-$98K	1.01%	36
2013 Q2	$2.89M	Buy	+108,626	New	+$3M	1.05%	28

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AT Bancorp's PFE Position: Q1 2019 in Review

AT Bancorp reduced its Pfizer (PFE) stake by 6.1% in Q1 2019, selling an estimated $55.1K and leaving 21,112 shares worth $851K. The position accounts for 0.1% of the portfolio, ranked #111.

AT Bancorp first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.06M in Q4 2013. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

AT Bancorp held 21,112 shares of Pfizer worth $851K as of Q1 2019.
AT Bancorp sold 1,375 Pfizer shares in Q1 2019, an estimated $55.1K.
Pfizer made up 0.1% of AT Bancorp's portfolio in Q1 2019, its #111 holding.
AT Bancorp first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
AT Bancorp's Pfizer position peaked at $3.06M in Q4 2013.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.